| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Kerr Drug recognizes that, for most of our customers, convenient access to products and services is a critical issue. That is why we go the extra mile to insure that our customers have the largest selection of things they need - everyday.
Sunrise Medical Canada Inc is a Concord, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sturdy Memorial Hospital Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Sturdy Memorial Hospital Inc. is based in Attleboro, MA. You can find more information on Sturdy Memorial Hospital Inc. at www.sturdymemorial.org
CNS Response, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.